Adalvo Ltd – Trademark Portfolio
Entity Type: 98
Adalvo Ltd holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ADALVO.
Malta Life Science Park,
Building 1 Level 4, Sir Temi Zammit Buildings, San Gwann Industrial Estate SGN 3000 SAN GWANN
Showing of trademarks Trademarks
Trademark Classifications
Adalvo Ltd's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Adalvo Ltd have?
Adalvo Ltd has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.
What trademark classes does Adalvo Ltd file in?
Adalvo Ltd files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are Adalvo Ltd's most well-known trademarks?
Adalvo Ltd's registered trademark portfolio includes well-known marks such as ADALVO. These are among 1 currently registered trademark in the portfolio.
What is Adalvo Ltd's trademark registration success rate?
Adalvo Ltd has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.